[artículo] 
inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 42-48

Título :	Predictors of response in generalized social phobia : Effect of age of onset
Tipo de documento:	texto impreso
Autores:	Michael Van Ameringen, Autor ; Jonathan Oakman, Autor ; Catherine Mancini, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 42-48
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastornos fóbicos, Ensayos controlados aleatorios, Sertralina, Índice de gravedad de la enfermedad.
Resumen:	Selective serotonin reuptake inhibitors (SSRIs) are the gold standard for the pharmacological treatment of generalized social phobia (GSP). However, little is known about the predictors of response to treatment. Two hundred and four outpatients with GSP were randomized to sertraline (Zoloft) or placebo, for a 20-week double-blind study, with a flexible dose range of sertraline 50 to 200 mg/d.
Link:	./index.php?lvl=notice_display&id=30977

[artículo] Predictors of response in generalized social phobia : Effect of age of onset [texto impreso] / Michael Van Ameringen, Autor ; Jonathan Oakman, Autor ; Catherine Mancini, Autor . - 2023 . - pp. 42-48.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 42-48

Palabras clave:	Trastornos fóbicos, Ensayos controlados aleatorios, Sertralina, Índice de gravedad de la enfermedad.
Resumen:	Selective serotonin reuptake inhibitors (SSRIs) are the gold standard for the pharmacological treatment of generalized social phobia (GSP). However, little is known about the predictors of response to treatment. Two hundred and four outpatients with GSP were randomized to sertraline (Zoloft) or placebo, for a 20-week double-blind study, with a flexible dose range of sertraline 50 to 200 mg/d.
Link:	./index.php?lvl=notice_display&id=30977